Novo Nordisk has launched PenCycle, a recycling initiative for pre-filled injection pens, designed to address the challenge of recycling injection pen devices.
A first-of-its-kind scheme in the UK, covering FlexPen® and FlexTouch® used to dispense insulin and other medications, will have community pharmacies playing a key role.
Users can return their devices to local participating community pharmacies or through pre-paid Royal Mail boxes or use an 'at home' collection pilot service for growth hormone pens.
The pens will then be returned to Denmark where the plastic will be recycled into a range of items, such as chairs and lamps, the Danish multinational pharmaceutical
company said.
It has been reported that several Austrians have been taken to the hospital after injecting fake Ozempic, as confirmed by health regulator.
Austria's Federal Office for Safety in Health Care (BASG) confirmed that the patients have suffered hypoglycaemia and seizures.
It is believed that the injections contained insulin instead of the weight loss drug, semaglutide.
The health regulator has urged doctors and patients to verify their medication stocks.